# HVPG-Guided Therapy Versus EVL Plus NSBB in Second Prophylaxis of Esophageal Variceal Bleeding

> **NCT03687216** · NA · UNKNOWN · sponsor: **West China Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Esophageal Varices in Cirrhosis of the Liver

## Interventions

- **PROCEDURE:** HVPG-guided therapy
- **PROCEDURE:** Routing Therapy

## Key facts

- **NCT ID:** NCT03687216
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09
- **Primary completion:** 2020-09
- **Final completion:** 2020-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2019-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03687216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03687216, "HVPG-Guided Therapy Versus EVL Plus NSBB in Second Prophylaxis of Esophageal Variceal Bleeding". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03687216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*